Dehydroepiandrosterone sulfate and mortality in elderly men and women
- PMID: 11549645
- DOI: 10.1210/jcem.86.9.7838
Dehydroepiandrosterone sulfate and mortality in elderly men and women
Abstract
Dehydroepiandrosterone sulfate levels have been inversely related with cardiovascular mortality in men, but findings have been inconsistent, and there are few data in women. We examined the relationship between baseline circulating dehydroepiandrosterone sulfate levels and subsequent all-cause and cardiovascular mortality in 963 men and 1171 women, 65-76 yr old, surveyed in 1991-1995, and followed up until August 2000 (when 296 deaths had occurred). All-cause and cardiovascular disease mortality rates were highest in the lowest dehydroepiandrosterone sulfate quartile in men; and thereafter, rates did not differ significantly in the upper three quartiles. This pattern remained after excluding those with previous history of cardiovascular disease and, in multivariate analyses, was independent of age, cigarette smoking habit, systolic blood pressure, body mass index, blood cholesterol, and steroid use. There was no significant association of dehydroepiandrosterone sulfate and mortality in women. The multivariate adjusted relative risks for all-cause mortality by sex-specific increasing quartile of dehydroepiandrosterone sulfate were 1.00, 0.66 (95% confidence interval, 0.44-1.01), 0.70 (0.46-1.07), 0.73 (0.48-1.10), respectively, for men and 1.00, 0.71 (95% confidence interval, 0.41-1.24), 0.97 (0.58-1.62), and 1.14 (0.69-1.88), respectively, for women. In older men and women, there is no consistent relationship between dehydroepiandrosterone sulfate and all-cause or cardiovascular mortality. The highest mortality rates were observed in the lowest quartile in men, but the highest rates were in the highest quartile in women.
Similar articles
-
Low serum levels of dehydroepiandrosterone sulfate predict all-cause and cardiovascular mortality in elderly Swedish men.J Clin Endocrinol Metab. 2010 Sep;95(9):4406-14. doi: 10.1210/jc.2010-0760. Epub 2010 Jul 7. J Clin Endocrinol Metab. 2010. PMID: 20610590
-
A prospective study of dehydroepiandrosterone sulfate, mortality, and cardiovascular disease.N Engl J Med. 1986 Dec 11;315(24):1519-24. doi: 10.1056/NEJM198612113152405. N Engl J Med. 1986. PMID: 2946952
-
Dehydroepiandrosterone and its sulfate predict the 5-year risk of coronary heart disease events in elderly men.J Am Coll Cardiol. 2014 Oct 28;64(17):1801-10. doi: 10.1016/j.jacc.2014.05.076. Epub 2014 Oct 21. J Am Coll Cardiol. 2014. PMID: 25443702
-
Dehydroepiandrosterone, dehydroepiandrosterone sulphate and cardiovascular disease.J Endocrinol. 1996 Sep;150 Suppl:S149-53. J Endocrinol. 1996. PMID: 8943798 Review.
-
[Physiology of dehydroepiandrosterone and dehydroepiandrosterone sulfate and its relationship with atherosclerosis].Zhonghua Bing Li Xue Za Zhi. 2006 Jul;35(7):426-8. Zhonghua Bing Li Xue Za Zhi. 2006. PMID: 17069681 Review. Chinese. No abstract available.
Cited by
-
Testosterone Deficiency and Nutritional Parameters as Predictors of All-Cause Mortality among Male Dialysis Patients.Nutrients. 2022 Oct 24;14(21):4461. doi: 10.3390/nu14214461. Nutrients. 2022. PMID: 36364724 Free PMC article.
-
Patterns of change in cardiovascular risk assessments and ankle brachial index among Puerto Rican adults.PLoS One. 2021 Jan 20;16(1):e0245236. doi: 10.1371/journal.pone.0245236. eCollection 2021. PLoS One. 2021. PMID: 33471871 Free PMC article.
-
Plasma Dehydroepiandrosterone Sulfate and Cardiovascular Disease Risk in Older Men and Women.J Clin Endocrinol Metab. 2020 Dec 1;105(12):e4304-27. doi: 10.1210/clinem/dgaa518. J Clin Endocrinol Metab. 2020. PMID: 32785663 Free PMC article.
-
The Effects of 12 Weeks of a Combined Exercise Program on Physical Function and Hormonal Status in Elderly Korean Women.Int J Environ Res Public Health. 2019 Oct 30;16(21):4196. doi: 10.3390/ijerph16214196. Int J Environ Res Public Health. 2019. PMID: 31671514 Free PMC article. Clinical Trial.
-
Dihydrotestosterone is a predictor for mortality in males with community-acquired pneumonia: results of a 6-year follow-up study.Respir Res. 2018 Dec 4;19(1):240. doi: 10.1186/s12931-018-0947-0. Respir Res. 2018. PMID: 30514319 Free PMC article. Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources